paul-nioi-2

A man smiles while wearing a blue suit jacket and red tie

kirk-brown4

A man smiles while wearing a pink button-down shirt and black vest

aiming-yu-lcms-2024

A microscopic view of white, orange, and green molecules

untitled-design-2024-05-17t113826-146-1

A man in a white coat sitting at a computer

phillip-sharp-22-09-26-mit-koch-institute-steve-boxall-3021-color-portrait

Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.

Silencing genes to prevent disease with RNAi drugs

News

A 3D illustration of a human brain, an organ that scientists can target with oligonucleotide gene therapy to treat neurological diseases.

61338-october-11th-webinar-banners-istock-image-1-1

Julia Alterman, PhD

Molecular Devices

Bio-Rad logo

Bio-Rad Laboratories

synthego-logo

Synthego

Optimizing the chemical architecture of siRNA improves its therapeutic potential for neurodegenerative disorders.

Oligonucleotide-based gene therapy&nbsp;

Webinars

Discover the function of novel noncoding RNA molecules and their therapeutic applications in neurodegeneration and infectious diseases.

Drug Discovery News

Noncoding RNA molecules are involved in key cellular processes affecting neurodevelopment and immunity.

Noncoding RNA in Health and Disease

june-2025-cover

June 2025

Tackling mycoplasma contamination in biotherapeutic production

80760-webinar-banners-july-23-kr1800x900-plain-istock

Thermo Fisher Scientific

DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.

untitled-2

primary-lockup-p-500-1-64e0fe115-1

Salad Technologies

Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.

Computational approaches to drug design

Compendium

Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.

article

Diagram showing how patient-derived somatic cells are reprogrammed into iPSCs using Yamanaka factors and then differentiated into specialized cell types such as neurons, cardiomyocytes, and hepatocytes.

ips-cells-image

BPS Bioscience

Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.

RNA interference

Silencing genes to prevent disease with RNAi drugs

Oligonucleotide-based gene therapy

Noncoding RNA in Health and Disease

Subscribe to our eNewsletters

Sponsored

June 2025